Pharmaceutical companies Eli Lilly and Novo Nordisk hold the patents for tirzepatide and semaglutide, limiting availability to only branded medications like Mounjaro, Zepbound, Ozempic, Wegovy, and Rybelsus, which can cost $800$1,500 per month without insurance
ONeil, J
The glucagon receptor component is thought largely on the basis of preclinical data to increase energy expenditure and promote fat breakdown (lipolysis), which may contribute to the substantial weight loss observed in early trials
Anti-Aging & Longevity Restores mitochondrial dynamics, countering age-related decline
Plans are offered as a subscription service which you can cancel at any time
[DOI] [PubMed] [Google Scholar] 115.Kelly AS, Auerbach P, Barrientos-Perez M, et al